Asset Details
Do you wish to reserve the book?
One-year costs of bilateral or single internal mammary grafts in the Arterial Revascularisation Trial
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
One-year costs of bilateral or single internal mammary grafts in the Arterial Revascularisation Trial
Do you wish to request the book?
One-year costs of bilateral or single internal mammary grafts in the Arterial Revascularisation Trial
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
One-year costs of bilateral or single internal mammary grafts in the Arterial Revascularisation Trial
2017
Overview
ObjectiveCoronary artery bypass grafting (CABG) using bilateral internal mammary arteries (BIMA) may improve survival over CABG using single internal mammary arteries (SIMA), but may be surgically more complex (and therefore costly) and associated with impaired sternal wound healing. We report, for the first time, a detailed comparison of healthcare resource use and costs over 12 months, as part of the Arterial Revascularisation (ART) Trial.Methods3102 patients in 28 hospitals in seven countries were randomised to CABG surgery using BIMA (n=1548) or SIMA (n=1554). Detailed resource use data were collected covering surgery, the initial hospital episode, and for 12 months post randomisation. Using UK unit costs, total costs were calculated and compared between trial arms and for subgroups.ResultsPatients randomised to BIMA spent 20 min longer in theatre (95% CI 15 to 25, p<0.001) and also required more treatment for sternal wound problems. Mean (SD) total costs per patient at 12 months were £13 839 (£10 534) for BIMA and £12 717 (£9719) for SIMA (mean cost difference £1122, 95% CI £407 to £1838, p=0.002). No tests for interaction between subgroups and treatment allocation were significant.ConclusionsAt 12 months from randomisation, mean costs were approximately 9% higher in BIMA than SIMA patients, primarily due to longer time in theatre and in-hospital stay, and slightly higher costs related to sternal wound problems during follow-up. Follow-up to the primary trial endpoint of 10 years will reveal whether longer-term differences emerge in graft patency or in overall survival.Trial registration numberControlled-trials.com (ISRCTN46552265).
Publisher
BMJ Publishing Group LTD
Subject
/ Brazil
/ Coronary Artery Disease - diagnostic imaging
/ Coronary Artery Disease - economics
/ Coronary Artery Disease - physiopathology
/ Coronary Artery Disease - surgery
/ Europe
/ Female
/ Humans
/ India
/ Internal Mammary-Coronary Artery Anastomosis - adverse effects
/ Internal Mammary-Coronary Artery Anastomosis - economics
/ Internal Mammary-Coronary Artery Anastomosis - methods
/ Male
/ Patients
/ Postoperative Complications - economics
/ Postoperative Complications - therapy
/ Stents
